GAO Guangchuan, WEI Chunyan, KUANG Jianhua. Changes of immune and inflammation related indexes in children with Kawasaki disease at acute stageand their relationships with prognosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(14): 24-27. DOI: 10.7619/jcmp.20210984
Citation: GAO Guangchuan, WEI Chunyan, KUANG Jianhua. Changes of immune and inflammation related indexes in children with Kawasaki disease at acute stageand their relationships with prognosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(14): 24-27. DOI: 10.7619/jcmp.20210984

Changes of immune and inflammation related indexes in children with Kawasaki disease at acute stageand their relationships with prognosis

More Information
  • Received Date: March 08, 2021
  • Available Online: July 25, 2021
  • Published Date: July 27, 2021
  •   Objective  To analyze the changes of CD64 on the surface of neutrophils, growth differentiation factor-15 (GDF-15) and serum amyloid A (SAA) in children with Kawasaki disease (KD) at acute phase and their relationships with prognosis.
      Methods  The clinical materials of 105 children with KD at acute phase (KD group) in authors'hospital were retrospectively analyzed, and 110 healthy children with physical examination in the same period were selected as control group. Children in the KD group were treated with immunoglobulin (IVIG) after admission, and the levels of CD64 on the surface of neutrophils in the peripheral blood, GDF-15 and SAA were compared between the KD group and the control group. According to the condition of coronary artery lesions (CAL) at 3 months after onset, the children were divided into CAL group and non-CAL group, and the levels of CD64 on the surface of neutrophils in the peripheral blood, GDF-15 and SAA were compared between the two groups before treatment. Receiver operating characteristic (ROC) curve was used to evaluate the value of the above indicators in predicting the occurrence of CAL in children with KD.
      Results  After treatment, the levels of CD64 on the surface of neutrophils in the peripheral blood, GDF-15 and SAA in the KD group were significantly lower than those before treatment, and the levels of above indicators before and after treatment in the KD group were significantly higher than those in the control group (P < 0.05). In the KD group, the incidence rate and severity of CAL at the early onset were significantly higher than those at 3 months after onset (P < 0.05). The levels of CD64 on the surface of neutrophils in the peripheral blood, GDF-15 and SAA before treatment in the CAL group (n=31) were significantly higher than those in the non-CAL group (n=74) (P < 0.05). ROC curve analysis showed that the levels of CD64 on the surface of neutrophils in the peripheral blood, GDF-15 and SAA before treatment had high predictive values for CAL in children with KD[area under the curve (AUC)=0.632, 0.846, 0.775, P < 0.05], and their cut-off values were 78.60%, 1 655.39 ng/mL and 795.41 mg/L, and the combination of the three indexes had the highest predictive values for prognosis (AUC=0.908, P < 0.05).
      Conclusion  The CD64 on the surface of neutrophils, GDF-15 and SAA may be involved in the progression of KD at acute phase, and their levels before treatment can predict incidence of CAL in children with KD at 3 months after onset.
  • [1]
    ZHANG X Y, YANG T T, HU X F, et al. Circulating adipokines are associated with Kawasaki disease[J]. Pediatr Rheumatol Online J, 2018, 16(1): 33. doi: 10.1186/s12969-018-0243-z
    [2]
    MIYAKOSHI C, YAMAMOTO Y, YAMAKAWA M, et al. Heart rate, responsiveness to intravenous immunoglobulin, and coronary artery aneurysms in Kawasaki disease[J]. J Pediatr, 2018, 200: 160-165, e5. doi: 10.1016/j.jpeds.2018.04.036
    [3]
    ISHIKAWA T, SEKI K. The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease[J]. BMC Cardiovasc Disord, 2018, 18(1): 30. doi: 10.1186/s12872-018-0765-9
    [4]
    KATO M, AYUSAWA M, WATANABE H, et al. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease[J]. Pediatr Int, 2018, 60(4): 342-348. doi: 10.1111/ped.13521
    [5]
    AYUSAWA M, SONOBE T, UEMURA S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition)[J]. Pediatr Int, 2005, 47(2): 232-234. doi: 10.1111/j.1442-200x.2005.02033.x
    [6]
    中华医学会儿科学分会心血管学组, 中华医学会儿科学分会免疫学组. 川崎病冠状动脉病变的临床处理建议[J]. 中华儿科杂志, 2012, 50(10): 746-749. doi: 10.3760/cma.j.issn.0578-1310.2012.10.008
    [7]
    刘晓燕, 王曼知, 陈芳, 等. 对氧磷酶1基因Q192R和L55M位点多态性与川崎病冠状动脉损伤的相关性[J]. 中华实用诊断与治疗杂志, 2020, 34(5): 470-473. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202005011.htm
    [8]
    王聪霞, 范雅洁. 冠心病血管内皮损伤与血管重构的研究进展[J]. 西安交通大学学报: 医学版, 2018, 39(4): 455-458. https://www.cnki.com.cn/Article/CJFDTOTAL-XAYX201804002.htm
    [9]
    蒋少华, 张凤书, 徐静, 等. soL-CXCL16、SAA、Cys-C水平与PCI术后冠状动脉再狭窄的相关性[J]. 心脑血管病防治, 2019, 19(6): 526-527, 530. https://www.cnki.com.cn/Article/CJFDTOTAL-XXFZ201906013.htm
    [10]
    肖昕, 吴梦琦. 彩色多普勒超声结合血清CD64水平对小儿川崎病临床诊断的价值研究[J]. 安徽医药, 2019, 23(6): 1160-1163. doi: 10.3969/j.issn.1009-6469.2019.06.029
    [11]
    许华, 熊丽丹, 文鹏. 单核细胞/中性粒细胞检测、颗粒凝集法、胶体金法诊断儿童肺炎支原体感染的价值比较[J]. 实用临床医药杂志, 2020, 24(17): 19-23. doi: 10.7619/jcmp.202017005
    [12]
    高文珺, 范晓晨. 川崎病患儿体内中性粒细胞CD64表达水平的变化及临床意义[J]. 安徽医学, 2018, 39(4): 442-444. doi: 10.3969/j.issn.1000-0399.2018.04.018
    [13]
    王新芳, 黄先玫, 王跃生, 等. 大剂量丙种球蛋白联合阿司匹林对川崎病患儿血管内皮因子和抵抗素及内脂素的影响[J]. 中华全科医学, 2018, 16(10): 1674-1676. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201810026.htm
    [14]
    FENG S Q, SU Y, LUO L, et al. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease[J]. Pediatr Res, 2018, 83(5): 999-1003. doi: 10.1038/pr.2018.16
    [15]
    王策, 于宪一. 320例川崎病患儿临床特点及冠状动脉损伤的高危因素分析[J]. 中国小儿急救医学, 2018, 25(12): 939-942, 947. doi: 10.3760/cma.j.issn.1673-4912.2018.12.012
    [16]
    张艺, 易岂建. 川崎病并发冠状动脉损害的高危因素[J]. 儿科药学杂志, 2019, 25(1): 59-63. https://www.cnki.com.cn/Article/CJFDTOTAL-EKYX201901020.htm
  • Related Articles

    [1]ZHOU Xiaoping, QIAO Jimin, LI Kai, WANG Zhimei. Efficacy of selective ulnar artery continuous circulatory compression in reducing radial artery occlusion in elderly patients with coronary heart disease undergoing coronary intervention[J]. Journal of Clinical Medicine in Practice, 2024, 28(3): 122-125, 130. DOI: 10.7619/jcmp.20233706
    [2]CONG Linqiang. Effect of plasma microRNA-34a level on degree of coronary artery disease in coronary atherosclerotic heart disease patients[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 102-106. DOI: 10.7619/jcmp.20215098
    [3]SHEN Qin, ZHANG Xiao, WU Ting, CHEN Liang. Clinical value of calcification scores of coronary artery CT angiography in evaluating coronary artery lesions and prognosis in patients with chronic angina pectoris[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 1-4, 8. DOI: 10.7619/jcmp.20213903
    [4]ZHANG Qiu, SUN Ling, WANG Qingjie, JI Yuan, JIANG Jianguang. Value of growth differentiation factor-15 in predicting risk of acute kidney injury in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 15-18. DOI: 10.7619/jcmp.202016004
    [5]YANG Fubao, LIU Jiaojiao. Value of echocardiogram and electrocardiogram in diagnosis of Kawasaki disease patients with coronary artery lesions[J]. Journal of Clinical Medicine in Practice, 2020, 24(6): 47-50. DOI: 10.7619/jcmp.202006013
    [6]WANG Jingwu, AI Fengying, WANG Dasheng, WU You, SU Yanjie, YANG Xinquan, WANG Daxin. Relationship between plasma TSP-1 and degree of coronary artery stenosis[J]. Journal of Clinical Medicine in Practice, 2018, (9): 6-10. DOI: 10.7619/jcmp.201809002
    [7]GENG Jiafeng. Correlation between N-terminal brain natriuretic peptide, lipoprotein (a) and coronary artery disease in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2016, (15): 14-16,20. DOI: 10.7619/jcmp.201615004
    [8]ZHUO Bo. Application effect of specialized nursing in coronary artery stent implantation[J]. Journal of Clinical Medicine in Practice, 2015, (4): 4-6. DOI: 10.7619/jcmp.201504002
    [9]ZHAO Yanzhong. Correlation between success rate of 64 row CT coronary artery examinationand anxiety and depression statuses of patients[J]. Journal of Clinical Medicine in Practice, 2014, (1): 116-118. DOI: 10.7619/jcmp.201401039
    [10]LI Xiaomei. Clinical values of HCY and hs-CRP in assessment of coronary artery changesin patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2014, (1): 20-22. DOI: 10.7619/jcmp.201401006
  • Cited by

    Periodical cited type(13)

    1. 付中英,杨燕玲,苏月华,于晗澍,李曼,朱凤芹,常红. 过敏性紫癫患儿外周血单个核细胞中ASC mRNA和NLRP3 mRNA表达水平及其与并发肾炎的关系. 中国妇幼健康研究. 2024(11): 20-31 .
    2. 刘阳,郝佳,卑雪,赵志佳,李阳. 过敏性紫癜患儿幽门螺杆菌感染及其对补体系统及炎症指标的影响. 中华医院感染学杂志. 2023(01): 138-141 .
    3. 郭爱玲. 学龄前期HP阳性儿童的免疫功能及生长发育的特点. 哈尔滨医药. 2023(01): 33-35 .
    4. 潘馨,刘佳奕,王艳,童敏,严方利,孙香娟. 幽门螺杆菌感染与儿童过敏性紫癜相关性的Meta分析. 医学信息. 2023(02): 92-98 .
    5. 黄丽琴,江秀华. 微生态制剂结合抗Hp三联方案治疗Hp阳性腹型AP患儿的效果. 数理医药学杂志. 2022(06): 893-895 .
    6. 孙文,黄雅玲,高健. 腹型过敏性紫癜患儿幽门螺杆菌感染与消化道出血的关系及相关因素探讨. 现代消化及介入诊疗. 2022(03): 355-358 .
    7. 王彩芳,么鑫,蔡花,张菂,黄翠影,梁晓亮,陈瑞珊,海冬. 肺炎链球菌、肺炎支原体、柯萨奇病毒及EB病毒感染与儿童过敏性紫癜肾炎的相关性研究. 临床和实验医学杂志. 2022(19): 2099-2103 .
    8. 刘力铭,张颖,赵子年,杨金玉,焦丽华,刘建丽,回广飞. 过敏性紫癜患儿呼吸道病毒感染特异性免疫球蛋白M检测及血清炎性因子变化. 临床军医杂志. 2021(07): 768-769 .
    9. 王杨. 过敏性紫癜患儿血清中Cys C、TM与T淋巴细胞亚群的关系及易感因素分析. 中国医学创新. 2021(21): 10-14 .
    10. 王士杰,胡方起,和平,余必信,邓芳. 黄芪颗粒联合氢化可的松琥珀酸钠治疗过敏性紫癜临床疗效与安全性探究. 中华中医药学刊. 2021(09): 169-172 .
    11. 王婧,韩磊,张震,夏毓,姜烜星,汤兴萍. 儿童过敏性紫癜感染幽门螺杆菌的危险因素分析与治疗研究. 系统医学. 2021(16): 31-34 .
    12. 李丹,张波,秦帅,刘宇. 微生态制剂结合抗幽门螺杆菌三联方案治疗儿童幽门螺杆菌阳性腹型过敏性紫癜的疗效分析. 中国现代医学杂志. 2021(19): 44-48 .
    13. 郭志伟. 探究儿童过敏性紫癜临床用药的治疗效果. 中国继续医学教育. 2021(30): 156-159 .

    Other cited types(1)

Catalog

    Article views (401) PDF downloads (32) Cited by(14)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return